Gaviscon double action suspension 150ml vials mint

$7.35

Gaviscon double action suspension 150ml vials mint

Quantity:

SKU: 678125503 Categories: , , Tags: ,

Description

Composition
Active substance:
Sodium alginate 500 mg, 213 mg sodium hydrogen carbonate, calcium carbonate, 325 mg;
Excipients:
Carbomer (974P) 65 mg, 40 mg methyl parahydroxybenzoate, propyl parahydroxybenzoate 6 mg Sodium hydroxide 26.67 mg sodium saccharinate 10 mg, 6 mg peppermint flavor, purified water to 10 ml.
Description:
Viscous, opaque slurry from nearly white to light brown color, with a mint odor.
Product form:
150 mlvo dark glass vials wrapped in shrink film with a polypropylene cap, providing a first control opening. Instructions for use under the label.
Contraindications
• hypersensitivity to any component of the drug;
• renal failure secondary to severe;
• Children up to age 12 years.
Carefully:
In the presence of the following diseases or conditions prior to use of the drug should consult a physician: hypercalcemia, nephrocalcinosis, urolithiasis with the formation of calcium-oxalate stones (see “Special instructions.”), Congestive heart failure (see “Special instructions.”), Hypophosphatemia , renal insufficiency mild (see. “Special instructions” section).
Indications
Symptomatic treatment of diseases associated with indigestion, gastric hyperacidity and gastroesophageal reflux (heartburn, acid regurgitation), a feeling of heaviness in the stomach after ingestion, including during pregnancy.
Interaction with other drugs
Since the calcium carbonate, part of the drug exhibits antacid activity between drug intake Geviskon® Dual Action and other drugs must be at least 2 hours, particularly while receiving H2-blockers of histamine receptors, antibiotics of the tetracycline group, digoxin, fluoroquinolone, iron salts, ketoconazole, neuroleptics, thyroid hormone, levothyroxine sodium, penicillamine, beta-blockers (atenolol, metoprolol, propranolol), corticosteroids, chloroquine, b sfosfonatami and estramustine.
Overdose
Symptoms may experience bloating.
Treatment: symptomatic.
pharmachologic effect
Pharmacological group:
Reflux esophagitis treatment for
Pharmacodynamics:
When ingestion of the active ingredients of the drug Geviskon® Dual Action quickly react with acidic stomach contents. Thus formed alginate gel with a pH close to neutral. Within three minutes, the gel forms a protective barrier on the surface of the gastric contents, preventing the appearance of gastroesophageal reflux (Scored reverse stomach contents into the esophagus) for up to four hours. In severe cases of reflux (regurgitation), the gel enters the esophagus, the stomach contents ahead of the rest, where it reduces irritation of esophageal mucosa. Calcium carbonate neutralizes hydrochloric acid gastric juice, facilitating a sense of heartburn. This effect is enhanced due to the presence in the composition of sodium hydrogen carbonate preparation which also has a neutralizing effect. Total acid-neutralizing activity of the drug in the lowest dose is about 10 ml of 10 mEq.
Pharmacokinetics:
The mechanism of action of the drug Geviskon® Dual Action is physical and does not depend on absorption into the systemic circulation.
Pregnancy and breast-feeding
The drug can be used during pregnancy and lactation.
Conditions of supply of pharmacies
Without recipe.
side effects
estimates of frequency of adverse reactions produced on the basis of the following criteria: very common (> 1/10), common (> 1/100, 1/1000, 1/10000,
Disorders of immune system: unknown frequency – anaphylactic and anaphylactoid reactions, hypersensitivity reactions (urticaria).
Violations of the respiratory system, thorax and mediastinum: unknown frequency – respiratory effects (bronchospasm).
Taking large amounts of calcium carbonate may cause alkalosis, hypercalcemia, acid rebound state, milk-alkali syndrome, constipation. These conditions typically arise in overdose.
If any of these instructions side effects are compounded, or you notice other effects not listed in the instructions, tell your doctor.
special instructions
In 10 ml of a suspension of sodium content of 127.25 mg (5.53 mmol). This should be considered as necessary dieting with a limited content of salts, for example, in congestive heart failure and renal failure mild.
10 ml of the suspension contains 130 mg (3.25 mmol) of calcium. Therefore, caution should be exercised in treating patients with hypercalcemia and nephrocalcinosis urolithiasis to form calcium oxalate stones.
The drug Geviskon®Dvoynoe Action contains a part of antacids, which can mask the symptoms of serious diseases of the gastrointestinal tract.
May decrease the effectiveness of the drug in patients with low acidity of gastric juice.
In children with gastroenteritis or suspected of having renal failure there is an increased risk of hypernatremia.
The preparation contains methyl parahydroxybenzoate and propyl parahydroxybenzoate, therefore, may cause allergic reactions (including delayed).
Effects on ability to transp. Wed. and fur .:
The drug has no effect on the ability to drive vehicles and mechanisms, as well as other classes of potentially hazardous activities that require high concentration and psychomotor speed reactions.
Storage conditions
At a temperature of not higher than 30 ° C. Keep out of the reach of children.
Dosing and Administration
Adults and children over 12 years: inside of 10-20 ml after meals and at bedtime (up to 4 times a day).
The maximum daily dose of 80 ml.
Do not use for a long time, if after 7 days of dosing symptoms persist, consult your doctor to review treatment.
Please read the instructions before taking the drug.
Information
Appearance may differ from that depicted in the picture. There are contraindications. You need to read the manual or consult with a specialist

Additional information

Weight0.100 kg
Manufacturer

Gaviscon

There are no reviews yet.

Add your review